Log In
CQMS
Make a Donation
Log In
Donate
Read our latest Annual Report highlighting TROG achievements
Read our Q & A with TROG Scientific Committee Chair A/Prof Hien Le
Get ready for World Radiotherapy Awareness Day 7 September
TROG ASM2026 - Abstracts now Open

Open Trials – In Follow Up

Open Trials – In Follow Up

TROG Cancer Research radiation therapy trials in follow up, are those trials that are fully approved and have now accepted the required number of participants. These participants are receiving active treatment and/or care by their doctors, with trial data still being collected.

Results of these trials will be made available once all participants have completed care and trial data is finalised. 

TROG 08.06 – STARS

Breast
A Randomised comparison of anastrozole commenced before and continuing during adjuvant radiotherapy for breast cancer versus anastrozole and subsequent anti-oestrogen therapy delayed until after radiotherapy.
Read More

TROG 12.02 – PET LABRADOR

Breast
PET scans for locally advanced breast cancer and diagnostic MRI to determine the extent of operation and radiotherapy
Read More

TROG 20.01 – CHEST RT

Lung
Chemotherapy Immunotherapy in Extensive Stage Small Cell with Thoracic Radiation therapy
Read More

ICR-CTSU/2015/15552/TROG 16.03 – CORE

Multiple
A randomised trial of Conventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases
Read More

TROG 14.02 – RAIDER

Bladder, Kidney & Prostate
A randomised phase II trial of adaptive image guided standard or dose escalated radiotherapy in the treatment of transitional cell carcinoma of the bladder
Read More

AGITG AG0407GR/TROG 08.08 – TOPGEAR

Gastrointestinal
A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.
Read More

AGITG/TROG 18.04 – MASTERPLAN

Gastrointestinal
A Randomised Phase II Study of MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease
Read More

MASC 03.18/TROG 21.01 – I-MAT

Skin
A randomised, placebo-controlled, Phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma
Read More

R2810-ONC-1788/TROG 17.11 – CPOST

Skin
A randomised, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous squamous cell carcinoma
Read More

TROG 14.01 – ENZARAD

Bladder, Kidney & Prostate
Randomised phase 3 trial of radiation plus androgen deprivation therapy with or without enzalutamide for high risk, clinically localised, prostate cancer
Read More

E33039 IAEA NPC

Head & Neck
A Situation Analysis of National Radiotherapy Resources and Patterns of Care for Patients with Nasopharyngeal Carcinoma in Low-Middle Income Countries: Can Enhancing the Quality of Radiotherapy Planning Improve Outcomes
Read More